Publication | Closed Access
Tenofovir disoproxil fumarate (TDF) suppresses lamivudine-resistant HBV replication in patients co-infected with HIV/HBV
17
Citations
0
References
2002
Year
Antiviral Drug DevelopmentAntiviral ResponseAntiviral TherapyVirologyChronic Viral InfectionAntiviral DrugHivMedicineTenofovir Disoproxil FumarateLamivudine-resistant Hbv Replication
No additional data available for this publication yet. Check back later!